Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients

Authors: Désirée Larenas-Linnemann, MD, Blanca María Morfin-Maciel, MD, Martín Bedolla-Barajas, MD, MSc, Ana López-Bago, MD, Elsy Maureen Navarrete Rodríguez, MD, MSc, María Dolores Mogica-Martínez, MD, José E. Gereda, MD, Mauricio Sarrazola Sanjuan, MD, MSc, Rosa Yazmín Cano Pedroza, MD, María Cecilia Cavallo, MD, Sergio de Jesús Romero Tapia, MD, Roberto A. Jossen, MD, José Miguel Fuentes Pérez, MD, Blanca E. Del Rio Navarro, MD, Erendira Rodríguez Zagal, MD, Pedro A. Piraino Sosa, MD, Yunuen Rocío Huerta Villalobos, MD, Pierre Chavez-Vereau, MD, Daniel Alberto García Imperial, MD, Margarita Olivares Gómez, MD, Francisco Valle Rodríguez, MD, Carlos Omar Zuñiga Reyes, MD, Mónica Rodríguez-González, MD, Claudia Ivonne Gallego Corella, MD, Juan Carlos Ivancevich, MD, María de la Luz Hortencia García Cruz, MD, María Susana Repka-Ramirez, MD, Mauricio Ernesto Flores Morales, MD, Juan Carlos Fernández De Córdova Aguirre, MD, MSc, Jorge A. Luna-Pech, MD, PhD, Daniela Rivero Yeverino, MD, Edgar Martínez Guzmán, MD, Cinthia Elizabeth Pérez Ortiz, MD, Leonor Villa Médica, MD

Source: World Allergy Organization Journal, Vol 16, Iss 5, Pp 100779- (2023)

Subject Terms: COVID-19, Allergen immunotherapy, Allergic asthma, Registry, Severe COVID-19, Oxygen therapy, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S193945512300039X; https://doaj.org/toc/1939-4551

Access URL: https://doaj.org/article/cd7960e0d97546b88f333cb19e028f58